News NICE backs UCB drug as first uncontrolled gMG therapy UCB's Rystiggo can be used by the NHS as a backup treatment for people with the rare autoimmune and neuromuscular disease gMG, says NICE.
News Amgen, AZ will pilot FDA's real-time clinical trial plan The FDA has published a plan to allow data from clinical trials to be reported to the agency as they occur in real time.
News UK study finds clue to rising cancer rates in younger people A study has found evidence that 11 cancers are becoming more common among young people in England, and points to a main driving factor.
News Can Purdue finally get its bankruptcy plan over the line? OxyContin manufacturer Purdue is on the brink of a bankruptcy deal that could put years of opioid liability litigation in its rearview mirror.
News UK Biobank patient data placed on sale in China There has been a major data security lapse at the UK Biobank, with "de-identified" data from its 500,000 volunteers listed for sale in China.
News Jazz and Lilly cancer drugs cleared for use by NHS Jazz's biliary tract cancer drug Ziihera and Lilly's Jaypirca for chronic lymphocytic leukaemia have been backed for NHS use in new NICE guidance.
News Parexel buys Vitrana to boost patient safety toolkit Contract research organisation Parexel has bought Vitrana and its AI-powered pharmacovigilance platform for an undisclosed sum.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.